Combined Application of Remote and Intra-Coronary Ischemic Conditioning in Acute Myocardial Infarction

NCT ID: NCT03155022

Last Updated: 2025-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

750 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-12

Study Completion Date

2023-10-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Infarct size is a major determinant of prognosis after AMI. Evidence indicates that the combination of intracoronary ischemic conditioning (ICIC) and remote ischemic conditioning (RIC) can significantly reduce infarct size in STEMI patients. Whether the combination of these two interventions may improve clinical outcome after STEMI remains unknown. The objective of the present study is to determine whether combination of ICIC and RIC can improve STEMI patients clinical outcome at 6 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myocardial Infarction, Acute

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RIC+ ICIC +

Patients with remote ischemic conditioning and intracoronary ischemic conditioning

Group Type EXPERIMENTAL

Remote ischemic conditioning and intracoronary ischemic conditioning

Intervention Type DEVICE

RIC: Four cycles of \[5 min brachial cuff inflation at 200 mmHg followed by 5 min of cuff deflation\] started as soon as possible prior to PCI reperfusion. At least one full cycle (inflation + deflation) has to be completed before PCI reperfusion.

ICIC: Four cycles of \[1 min balloon inflation followed by 1 min balloon deflation\] started as soon as possible after reopening of the culprit coronary artery (maximum within 3 minutes after reflow). The balloon will be placed carefully above the culprit lesion so as to minimize potential micro-embolization.

RCI - ICIC -

Control group with no remote ischemic conditioning and no intracoronary ischemic conditioning

Group Type OTHER

Patients with no remote ischemic conditioning and no intracoronary ischemic conditioning

Intervention Type DEVICE

Brachial cuff is positioned during 40 minutes but not inflated. No intracoronary balloon inflation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Remote ischemic conditioning and intracoronary ischemic conditioning

RIC: Four cycles of \[5 min brachial cuff inflation at 200 mmHg followed by 5 min of cuff deflation\] started as soon as possible prior to PCI reperfusion. At least one full cycle (inflation + deflation) has to be completed before PCI reperfusion.

ICIC: Four cycles of \[1 min balloon inflation followed by 1 min balloon deflation\] started as soon as possible after reopening of the culprit coronary artery (maximum within 3 minutes after reflow). The balloon will be placed carefully above the culprit lesion so as to minimize potential micro-embolization.

Intervention Type DEVICE

Patients with no remote ischemic conditioning and no intracoronary ischemic conditioning

Brachial cuff is positioned during 40 minutes but not inflated. No intracoronary balloon inflation.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All (male and female) patients, aged over 18,
* Presenting within 12 hours of the onset of chest pain,
* For whom the clinical decision was made to treat with percutaneous coronary intervention (PCI),
* ST segment elevation ≥ 0.2 mV in two contiguous ECG leads,
* Written informed consent obtained or oral informed consent certified by a third party.


* Patients with cardiogenic shock,
* Patients with uncontrolled (treated or untreated) hypertension (\> 180/110 mmHg),
* Patients with loss of consciousness or confused,
* Patients without health coverage,
* Patient with any legal protection measure,
* Female patients currently pregnant (oral diagnosis) or women of childbearing age who were not using contraception.

Exclusion Criteria

Patients with main occlusion localized on :

* LAD: distal or ostial segment,
* Non dominant RCA / CX: mid or distal segment,
* Dominant RCA / CX: distal segment,
* Any other arteries apart LAD/CX/RCA; Patients with evidence of coronary collaterals to the risk region (Rentrop score ≥ 2); Patients with an opened (TIMI \> 1) culprit coronary artery on initial admission coronary angiography or a failed PCI (final TIMI=0).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gilles Rioufol, Pr

Role: PRINCIPAL_INVESTIGATOR

Hôpital Louis Pradel 28 avenue Doyen Lépine, BP Lyon-Montchat, 69394LYON cedex 03

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Algemeen Ziekenhuis Sint Jan

Bruges, , Belgium

Site Status

CHU de Charleroi

Charleroi, , Belgium

Site Status

Universitair Ziekenhuis Antwerpen

Edegem, , Belgium

Site Status

Hopital Louis Pradel

Bron, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-A01683-50

Identifier Type: OTHER

Identifier Source: secondary_id

69HCL17_0032

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CARESS in Acute Myocardial Infarction
NCT00220571 COMPLETED PHASE3
Cohort of STEMI Patients
NCT02822638 COMPLETED
Delayed Postconditioning
NCT01483755 COMPLETED PHASE2